Nektar Therapeutics (NKTR) Climbed To A New High On Study Results

Nektar Therapeutics (NKTR) and Bristol-Myers Squibb (BMY) announced positive results from their Phase 1/2 study of the combination of Opdivo with Nektar's NKTR-214 on Saturday.

from RTT - Before the Bell http://ift.tt/2jpKHUE
via IFTTT